Kjellson Nina S

Director Kjellson sells 74.6K shares at $17.18–$17.32 for $1.3M as stock falls 43.7% from 52-week high

Kjellson Nina S, a director at Tyra Biosciences, executed 4 separate sales totaling 74,582 shares for $1,284,133.32 on November 6–7, 2024, at blended average price of $17.22. The sales reduced her holdings from 523.8K shares to 449.3K shares (a 14.2% reduction). The timing is notable: the stock is now trading at $16.11, down 43.7% from its 52-week high of $28.61, and has declined 24.3% over the past 30 days. The company is unprofitable with net income of $-24.0M over its most recent full fiscal year. These sales occurred just days after Kjellson executed 4 additional sales on October 31 and November 1, 2024, indicating a pattern of liquidation during a period of significant stock price weakness.

Director Nina S Kjellson sold 138,711 shares for $2,282,656.07 across 8 separate transactions from Oct 30 to Nov 1, reducing holdings 23.2%.

Director Kjellson executed 8 separate sales totaling 138,711 shares for $2,282,656.07 over three consecutive business days (Oct 30–Nov 1), at prices ranging from $16.17 to $17.16 and a blended average of $16.46. The transactions reduced her holdings from 597,217 to 458,506 shares, a 23.2% reduction in her position. This concentrated liquidation occurred while TYRA trades at $16.39 (current price), down 42.7% from its 52-week high of $28.61 and down 26.8% over the past 30 days, in a context where the company reported a full-year net loss of $18,702,000. The multi-day, multi-tranche structure and substantial reduction in absolute holdings warrant investor attention to the underlying business conditions that prompted a director to divest a significant portion of her stake.